ODT - Odonate Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
1.08B
Enterprise Value 3
859.97M
Trailing P/E
N/A
Forward P/E 1
-7.10
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
5.78
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
-7.46

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3110.96%
S&P500 52-Week Change 315.97%
52 Week High 343.75
52 Week Low 311.54
50-Day Moving Average 329.53
200-Day Moving Average 329.86

Share Statistics

Avg Vol (3 month) 3105.43k
Avg Vol (10 day) 398.8k
Shares Outstanding 532.08M
Float 13.82M
% Held by Insiders 111.18%
% Held by Institutions 195.35%
Shares Short (Oct 31, 2019) 41.41M
Short Ratio (Oct 31, 2019) 412.89
Short % of Float (Oct 31, 2019) 416.10%
Short % of Shares Outstanding (Oct 31, 2019) 44.41%
Shares Short (prior month Sep 30, 2019) 41.43M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-38.17%
Return on Equity (ttm)-66.93%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -115.31M
Net Income Avi to Common (ttm)-112.74M
Diluted EPS (ttm)-4.31
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)204.24M
Total Cash Per Share (mrq)6.37
Total Debt (mrq)2.24M
Total Debt/Equity (mrq)1.20
Current Ratio (mrq)8.41
Book Value Per Share (mrq)5.80

Cash Flow Statement

Operating Cash Flow (ttm)-93.88M
Levered Free Cash Flow (ttm)-53.95M